BEONE MEDICINES (06160.HK) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Dec8

UOB Securities Analysts Positive on BeiGene's Revenue Growth Potential

04:37

Dec7

Two Drugs of BeiGene Entered the Commercial Insurance Innovative Drugs Directory

03:19

Dec4

Brokers Adjust Ratings and Target Prices for Multiple Stocks

01:00

Nov24

BeiGene's Q3 Total Revenue Reached 1.4 Billion USD, Up 41% YoY

06:33

Nov17

BeiGene Adds Gene Editing Concept, Expanding Cell Therapy

08:28

Beyter Zhishen Reports Better-than-Expected Q3 2025 Earnings, Upgrading Full-Year Guidance

07:46

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(CST)

FY2025 Q3 Earning Release (HKD) Revenue 10.99 B, Net Income 971.6 M, EPS 0.6226

Aug6

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 10.32 B, Net Income 740.4 M, EPS 0.4709

May7

Earning Release(CST)

FY2025 Q1 Earning Release (HKD) Revenue 8.692 B, Net Income 9.88 M, EPS 0.0068

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More